A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression.
about
A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes.Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1α protein expression through the ubiquitin-proteasome degradation pathwayReduction of circulating PCSK9 and LDL-C levels by liver-specific knockdown of HNF1α in normolipidemic mice.High-fructose feeding promotes accelerated degradation of hepatic LDL receptor and hypercholesterolemia in hamsters via elevated circulating PCSK9 levelsA novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation
P2860
A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A novel posttranscriptional me ...... liver LDL receptor expression.
@ast
A novel posttranscriptional me ...... liver LDL receptor expression.
@en
type
label
A novel posttranscriptional me ...... liver LDL receptor expression.
@ast
A novel posttranscriptional me ...... liver LDL receptor expression.
@en
prefLabel
A novel posttranscriptional me ...... liver LDL receptor expression.
@ast
A novel posttranscriptional me ...... liver LDL receptor expression.
@en
P2093
P2860
P356
P1476
A novel posttranscriptional me ...... liver LDL receptor expression
@en
P2093
Chin Fung Kelvin Kan
Jingwen Liu
Vikram Shende
P2860
P304
P356
10.1194/JLR.M049429
P577
2014-05-02T00:00:00Z